<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title><![CDATA[Công ty TNHH Công nghệ Cosper Pharma]]></title><category><![CDATA[Công ty TNHH Công nghệ Cosper Pharma]]></category><description><![CDATA[Cosper là nhà sản xuất dược phẩm đáng tin cậy của Trung Quốc cung cấp các dịch vụ, API và sản phẩm trung gian CRO/CDMO. Nhà máy được chứng nhận GMP với chuỗi cung ứng trọn gói từ R&D đến sản xuất. Hãy liên hệ với chúng tôi ngay bây giờ.]]></description><link><![CDATA[https://vi.cosperpharma.com]]></link><language>vi</language><pubDate>Sun, 13 Sep 2026 02:36:00 GMT</pubDate><lastBuildDate>Sun, 13 Sep 2026 02:36:00 GMT</lastBuildDate><item><title><![CDATA[COA Daridorexant Hydrochloride]]></title><link><![CDATA[https://vi.cosperpharma.com/news/daridorexant-hydrochloride.html]]></link><pubDate><![CDATA[Fri, 14 Aug 2026 09:47:21 GMT]]></pubDate></item><item><title><![CDATA[Iminesiru cho Relebactam]]></title><link><![CDATA[https://vi.cosperpharma.com/news/iminesiru-for-relebactam.html]]></link><pubDate><![CDATA[Fri, 14 Aug 2026 03:33:50 GMT]]></pubDate></item><item><title><![CDATA[Nghi&#234;n cứu s&#224;ng lọc dạng tinh thể Trofinetide‌]]></title><link><![CDATA[https://vi.cosperpharma.com/news/screening-study-of-trofinetide-cocrystal-form.html]]></link><pubDate><![CDATA[Wed, 12 Aug 2026 02:38:02 GMT]]></pubDate></item><item><title><![CDATA[JACS: Merck đ&#227; hợp t&#225;c với Huanquan v&#224; Conquer Biotech để c&#244;ng khai to&#224;n bộ quy tr&#236;nh tổng hợp cho MK-0616.]]></title><link><![CDATA[https://vi.cosperpharma.com/news/jacs-merck-has-partnered-with-huanquan-and-conquer-biotech-to-publicly-disclose-the-total-synthesis-process-for-mk-0616.html]]></link><pubDate><![CDATA[Mon, 10 Aug 2026 09:50:59 GMT]]></pubDate></item><item><title><![CDATA[N&#234;n lựa chọn t&#225;c nh&#226;n chelat như thế n&#224;o cho c&#225;c hạt nh&#226;n ph&#243;ng xạ mục ti&#234;u?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/how-should-chelating-agents-be-selected-for-targeted-radionuclides.html]]></link><pubDate><![CDATA[Wed, 05 Aug 2026 09:17:22 GMT]]></pubDate></item><item><title><![CDATA[C&#244;ng nghệ Eutectic: Mở ra c&#225;nh cửa cho nghi&#234;n cứu v&#224; ph&#225;t triển thuốc mới v&#224; thuốc biến đổi]]></title><link><![CDATA[https://vi.cosperpharma.com/news/eutectic-technology-opening-the-door-to-new-drug-and-modified-drug-r-d.html]]></link><pubDate><![CDATA[Tue, 04 Aug 2026 03:03:10 GMT]]></pubDate></item><item><title><![CDATA[Th&#244;ng tin trung gian dược phẩm]]></title><link><![CDATA[https://vi.cosperpharma.com/news/pharmaceutical-intermediate-information.html]]></link><pubDate><![CDATA[Tue, 28 Jul 2026 03:47:46 GMT]]></pubDate></item><item><title><![CDATA[Ph&#226;n t&#237;ch quy tr&#236;nh tổng hợp loại thuốc ch&#237;nh của Eli Lilly: Tirzepatide]]></title><link><![CDATA[https://vi.cosperpharma.com/news/analysis-of-the-synthesis-process-for-eli-lilly-s-key-drug-tirzepatide.html]]></link><pubDate><![CDATA[Mon, 27 Jul 2026 06:52:33 GMT]]></pubDate></item><item><title><![CDATA[Con đường tổng hợp của Trofinetide]]></title><link><![CDATA[https://vi.cosperpharma.com/news/synthetic-route-of-trofinetide.html]]></link><pubDate><![CDATA[Fri, 24 Jul 2026 08:39:34 GMT]]></pubDate></item><item><title><![CDATA[Phương ph&#225;p b&#224;o chế Cagrilintide]]></title><link><![CDATA[https://vi.cosperpharma.com/news/preparation-method-of-cagrilintide.html]]></link><pubDate><![CDATA[Thu, 16 Jul 2026 03:36:35 GMT]]></pubDate></item><item><title><![CDATA[Thuốc ức chế JAK b&#244;i ngo&#224;i da đầu ti&#234;n tr&#234;n thế giới điều trị bệnh “ch&#224;m tay” – Kem Delgocitinib]]></title><link><![CDATA[https://vi.cosperpharma.com/news/the-world-s-first-topical-jak-inhibitor-for-treating-hand-eczema-delgocitinib-cream.html]]></link><pubDate><![CDATA[Tue, 14 Jul 2026 05:53:02 GMT]]></pubDate></item><item><title><![CDATA[Thiết kế m&#225;y tạo chất thải dựa tr&#234;n AI để ph&#225;t triển thuốc hạt nh&#226;n: Những th&#225;ch thức]]></title><link><![CDATA[https://vi.cosperpharma.com/news/ai-driven-design-of-chelators-for-nuclear-drug-development-challenges.html]]></link><pubDate><![CDATA[Fri, 10 Jul 2026 06:25:33 GMT]]></pubDate></item><item><title><![CDATA[Khuyến nghị về lộ tr&#236;nh ph&#225;t triển v&#224; tổng hợp Brexpiprazole]]></title><link><![CDATA[https://vi.cosperpharma.com/news/recommendation-for-the-development-and-synthesis-route-of-brexpiprazole.html]]></link><pubDate><![CDATA[Thu, 09 Jul 2026 08:32:44 GMT]]></pubDate></item><item><title><![CDATA[Thần dược trị c&#250;m A – Baloxavir marboxil]]></title><link><![CDATA[https://vi.cosperpharma.com/news/the-miracle-drug-for-influenza-a-baloxavir-marboxil.html]]></link><pubDate><![CDATA[Tue, 07 Jul 2026 07:54:05 GMT]]></pubDate></item><item><title><![CDATA[Thuốc kh&#225;ng virus: Amenamevir]]></title><link><![CDATA[https://vi.cosperpharma.com/news/antiviral-drug-amenamevir.html]]></link><pubDate><![CDATA[Fri, 03 Jul 2026 09:43:22 GMT]]></pubDate></item><item><title><![CDATA[Vibegron: Lộ tr&#236;nh tổng hợp v&#224; đề xuất dự &#225;n]]></title><link><![CDATA[https://vi.cosperpharma.com/news/vibegron-project-proposal-and-synthesis-route.html]]></link><pubDate><![CDATA[Tue, 30 Jun 2026 08:34:43 GMT]]></pubDate></item><item><title><![CDATA[Tổng quan v&#224; điều chế Icatibant axetat]]></title><link><![CDATA[https://vi.cosperpharma.com/news/overview-and-preparation-of-icatibant-acetate.html]]></link><pubDate><![CDATA[Tue, 30 Jun 2026 08:33:59 GMT]]></pubDate></item><item><title><![CDATA[B&#224;i viết chuy&#234;n s&#226;u: N-methyl h&#243;a, α -methyl h&#243;a, D-amino axit, axit amin kh&#244;ng tự nhi&#234;n cho polypeptide]]></title><link><![CDATA[https://vi.cosperpharma.com/news/in-depth-article-n-methylation-methylation-d-amino-acids-unnatural-amino-acids-for-polypeptide.html]]></link><pubDate><![CDATA[Tue, 09 Jun 2026 09:55:58 GMT]]></pubDate></item><item><title><![CDATA[Tại sao Pralatrexate quan trọng trong điều trị ung thư hiện đại?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/why-is-pralatrexate-important-in-modern-cancer-treatment.html]]></link><pubDate><![CDATA[Tue, 02 Jun 2026 06:09:11 GMT]]></pubDate></item><item><title><![CDATA[MAAA-1162a được tổng hợp như thế n&#224;o?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/how-is-maaa-1162a-synthesized.html]]></link><pubDate><![CDATA[Fri, 29 May 2026 10:08:20 GMT]]></pubDate></item><item><title><![CDATA[Sự tổng hợp doxercalciferol]]></title><link><![CDATA[https://vi.cosperpharma.com/news/the-synthesis-of-doxercalciferol.html]]></link><pubDate><![CDATA[Thu, 28 May 2026 09:36:32 GMT]]></pubDate></item><item><title><![CDATA[Với c&#225;c thanh quy định GLP-1 được đặt ở ngưỡng nhận dạng 0,1%, ti&#234;u chuẩn tham chiếu phức hợp Sucrose Octasulfate-nh&#244;m (Tạp chất Orforglipron 18) của bạn c&#243; đủ mạnh để ph&#226;n hủy cưỡng bức v&#224; lưu trữ ANDA kh&#244;ng?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/with-glp-1-regulatory-bars-set-at-a-0-1-identification-threshold-is-your-sucrose-octasulfate-aluminum-complex-orforglipron-impurity-18-reference-standard-robust-enough-for-forced-degradation-and-anda-filing.html]]></link><pubDate><![CDATA[Thu, 28 May 2026 03:17:40 GMT]]></pubDate></item><item><title><![CDATA[Migalastat biến đổi phương ph&#225;p điều trị bệnh Fabry như thế n&#224;o?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/how-does-migalastat-transform-fabry-disease-treatment.html]]></link><pubDate><![CDATA[Tue, 26 May 2026 02:25:14 GMT]]></pubDate></item><item><title><![CDATA[D&#242;ng x&#250;c t&#225;c sinh học cho ph&#233;p sản xuất peptide v&#242;ng lớn Enlicitide]]></title><link><![CDATA[https://vi.cosperpharma.com/news/biocatalytic-cascades-enable-the-manufacturing-of-the-macrocyclic-peptide-enlicitide.html]]></link><pubDate><![CDATA[Thu, 21 May 2026 09:36:41 GMT]]></pubDate></item><item><title><![CDATA[Điều g&#236; khiến Osimertinib trở th&#224;nh liệu ph&#225;p đột ph&#225; trong điều trị ung thư phổi hiện đại?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/what-makes-osimertinib-a-breakthrough-therapy-for-modern-lung-cancer-treatment.html]]></link><pubDate><![CDATA[Mon, 18 May 2026 03:09:49 GMT]]></pubDate></item><item><title><![CDATA[Điều g&#236; khiến Sapropterin quan trọng trong việc quản l&#253; PKU?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/what-makes-sapropterin-important-for-managing-pku.html]]></link><pubDate><![CDATA[Wed, 13 May 2026 05:49:25 GMT]]></pubDate></item><item><title><![CDATA[Pralatrexat l&#224; g&#236;?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/what-is-pralatrexate.html]]></link><pubDate><![CDATA[Mon, 11 May 2026 07:02:10 GMT]]></pubDate></item><item><title><![CDATA[Zanubrutinib l&#224; g&#236;?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/what-is-zanubrutinib.html]]></link><pubDate><![CDATA[Mon, 11 May 2026 07:02:50 GMT]]></pubDate></item><item><title><![CDATA[T&#225;c dụng v&#224; hiệu quả của carfilzomib l&#224; g&#236;?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/what-are-the-effects-and-efficacy-of-carfilzomib.html]]></link><pubDate><![CDATA[Mon, 11 May 2026 07:03:43 GMT]]></pubDate></item><item><title><![CDATA[Utpatinib l&#224; g&#236;?]]></title><link><![CDATA[https://vi.cosperpharma.com/news/what-is-utpatinib.html]]></link><pubDate><![CDATA[Mon, 11 May 2026 07:04:21 GMT]]></pubDate></item></channel></rss>